TRANSCELERATE BIOPHARMA INC: Form 990, tax year 2024
View the entire original 990 at ProPublica ↗
- Organization
- TRANSCELERATE BIOPHARMA INC (EIN 46-0886344)
- Tax period
- 2024-01-01 to 2024-12-31
- Filed
- 2025-05-14
- IRS object ID
- 202501349349301535
- Schema version
- 2024v5.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2025-05-14T07:33:35-05:00 | ReturnTs |
| Tax Period End | 2024-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 871353108 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | EISNER ADVISORY GROUP LLC | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 130 NORTH 18TH STREET SUITE 3000 | AddressLine1Txt |
| City | PHILADELPHIA | CityNm |
| State Abbreviation | PA | StateAbbreviationCd |
| ZIP | 191032757 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2024-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 460886344 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | TRANSCELERATE BIOPHARMA INC | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | TRAN | BusinessNameControlTxt |
| Phone | 4845391230 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 300 CONSHOHOCKEN STATE ROAD 420 | AddressLine1Txt |
| City | WEST CONSHOHOCKEN | CityNm |
| State Abbreviation | PA | StateAbbreviationCd |
| ZIP | 19428 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | JANICE CHANG | PersonNm |
| Person Title | CEO | PersonTitleTxt |
| Phone | 4845391230 | PhoneNum |
| Signature | 2025-05-08 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IRS Responsible Prty Info Curr | 0 | IRSResponsiblePrtyInfoCurrInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | HELEN M MARTIN | PreparerPersonNm |
| PTIN | P01330899 | PTIN |
| Phone | 2158818800 | PhoneNum |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2024 | TaxYr |
| Build TS | 2025-03-06 01:10:19Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | JANICE CHANG | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 300 CONSHOHOCKEN STATE ROAD 420 | AddressLine1Txt |
| City | WEST CONSHOHOCKEN | CityNm |
| State Abbreviation | PA | StateAbbreviationCd |
| ZIP | 19428 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $38,595,799 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c | Yes (X) | Organization501cInd |
| Website Address | WWW.TRANSCELERATEBIOPHARMAINC.COM | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 2012 | FormationYr |
| Legal Domicile State | DE | LegalDomicileStateCd |
| Activity Or Mission | IMPROVE THE HEALTH OF PEOPLE IN THE WORLD BY ENHANCING THE R&D OF INNOVATIVE THERAPIES. | ActivityOrMissionDesc |
| Voting Members Governing Body | 22 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 21 | VotingMembersIndependentCnt |
| Total Employee | 33 | TotalEmployeeCnt |
| Total Volunteers | 27 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $0 | PYContributionsGrantsAmt |
| CY Contributions Grants | $0 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $33,395,000 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $37,402,000 | CYProgramServiceRevenueAmt |
| PY Investment Income | $773,812 | PYInvestmentIncomeAmt |
| CY Investment Income | $1,193,799 | CYInvestmentIncomeAmt |
| PY Other Revenue | $0 | PYOtherRevenueAmt |
| CY Other Revenue | $0 | CYOtherRevenueAmt |
| PY Total Revenue | $34,168,812 | PYTotalRevenueAmt |
| CY Total Revenue | $38,595,799 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $0 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $0 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $9,951,190 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $9,759,153 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $0 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $22,569,959 | PYOtherExpensesAmt |
| CY Other Expenses | $21,980,786 | CYOtherExpensesAmt |
| PY Total Expenses | $32,521,149 | PYTotalExpensesAmt |
| CY Total Expenses | $31,739,939 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $1,647,663 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $6,855,860 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $48,107,662 | TotalAssetsBOYAmt |
| Total Assets EOY | $55,325,009 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $36,490,338 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $36,830,722 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $11,617,324 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $18,494,287 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | THE ORGANIZATION'S MISSION IS TO COLLABORATE ACROSS THE GLOBAL BIOPHARMACEUTICAL R&D COMMUNITY TO IDENTIFY, DESIGN AND FACILITATE IMPLEMENTATION OF SOLUTIONS DESIGNED TO DRIVE THE EFFICIENT, EFFECTIVE AND HIGH QUALITY DELIVERY OF NEW MEDICINES. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $22,012,036 | ExpenseAmt |
| Revenue | $37,402,000 | RevenueAmt |
| Desc | IN 2024, TRANSCELERATE CONTINUED TO FOCUS ON ADVANCING CLINICAL RESEARCH BY HARNESSING COLLABORATION TO ADDRESS SYSTEMIC CHALLENGES AND ACCELERATING INNOVATION. THE ORGANIZATION MADE IMPORTANT STRIDES AIMED AT BRIDGING THE GAP BETWEEN CLINICAL RESEARCH AND PATIENT CARE, MAKING VITAL TRIAL INFORMATION MORE EASILY ACCESSIBLE AND HELPING THE INDUSTRY DELIVER LIFE-SAVING MEDICINES BETTER AND FASTER.TRANSCELERATE'S PORTFOLIO OF WORK ALIGNED TO THREE CORE AREAS: 1) TRANSFORMING CONNECTIVITY, TO REDEFINE HOW RESEARCH AND CARE INTERACT; 2) INFORMATION SHARING AND REUSE, TO LEVERAGE EXISTING DATA FOR ENABLING FASTER DISCOVERIES; AND 3) INNOVATIVE TRIAL DESIGN, TO PUT PATIENTS AT THE HEART OF CLINICAL TRIALS.MEMBERSHIP GREW TO MORE THAN 20 LEADING BIOPHARMA COMPANIES, FURTHER STRENGTHENING COLLABORATIVE EFFORTS. THE ORGANIZATION LED 15 ACTIVE INITIATIVES AND COMPLETED THE YEAR WITH MORE THAN 35 TOOLS AND SOLUTIONS IN PROGRESS. SINCE ITS FOUNDING IN 2012, TRANSCELERATE HAS DEVELOPED MORE THAN 570 TOOLKITS, EMPLOYING AN APPROACH THAT COMBINES RAPID IMPROVEMENTS FOR IMMEDIATE IMPLEMENTATION WITH LONG-TERM SOLUTIONS TO TRANSFORM THE R&D ECOSYSTEM.SOME HIGHLIGHTS OF TRANSCELERATE'S PORTFOLIO OF WORK IN 2024: DIGITAL DATA FLOW INITIATIVE: MODERNIZE CLINICAL TRIALS BY ENABLING DIGITIZATION OF PROTOCOLS, AUTOMATION OF DATA FLOW AND STREAMLINING THE R&D PROCESS, REDUCING CYCLE TIMES AND IMPROVING DATA QUALITY. HISTORICAL TRIAL DATA SHARING INITIATIVE: ENABLE COMPANIES TO IMPROVE STUDY DESIGN, REDUCE PLACEBO USE AND ACCELERATE DRUG DEVELOPMENT BY RESPONSIBLY AND SECURELY SHARING AND REUSING DATA. MODERNIZING INDIVIDUAL CASE SAFETY REPORT (ICSR) MANAGEMENT INITIATIVE: SEEKS TOS TRANSFORM THE ICSR SYSTEM, WHICH WOULD REDUCE DUPLICATION, ENABLE REAL-TIME SAFETY DATA ACCESS AND ENHANCE PATIENT SAFETY THROUGH MORE EFFICIENT PROCESSING. EMBEDDED PRAGMATIC TRIALS INITIATIVE: AIMS TO FACILITATE THE ABILITY TO CONDUCT PRAGMATIC CLINICAL TRIALS BY DEVELOPING RESOURCES, PROVING FEASIBILITY AND ADDRESSING OPERATIONAL DIFFERENCES TO BETTER INTEGRATE RESEARCH INTO ROUTINE CARE. MODERNIZING CLINICAL TRIAL CONDUCT INITIATIVE: ADVANCE TRIALS BY HELPING COMPANIES ADOPT PATIENT-FRIENDLY TECHNOLOGIES LIKE TELEMEDICINE, OFFERING MORE FLEXIBILITY WHILE ENSURING PATIENT SAFETY AND DATA INTEGRITY.TRANSCELERATE COLLABORATED WITH VARIOUS ORGANIZATIONS INCLUDING THE ASSOCIATION OF CLINICAL RESEARCH ORGANIZATIONS (ACRO), THE EU PATIENT-CENTRIC CLINICAL TRIAL PLATFORMS (EU-PEARL), AND THE CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM (CDISC).THE ACRO COLLABORATION RESULTED IN CO-CREATION OF TOOLS TO SUPPORT THE IMPLEMENTATION OF THE INTERNATIONAL COUNCIL FOR HARMONIZATION'S NEW GOOD CLINICAL PRACTICE GUIDELINES AROUND THE WORLD. THROUGH THE EU-PEARL PARTNERSHIP, PROGRESS WAS MADE TO SIMPLIFY THE APPROACH TO PATIENT-FRIENDLY PLATFORM TRIALS. THE COLLABORATION WITH CDISC HELPED TO ACCELERATE THE DEVELOPMENT OF CLINICAL DATA EXCHANGE STANDARDS FOR PROTOCOL DIGITIZATION. TRANSCELERATE ENGAGED IN PRODUCTIVE DIALOGUE AND ACTION WITH GLOBAL HEALTH AUTHORITIES TO ACCELERATE THE PACE OF CHANGE THROUGH IMPLEMENTATION OF A HOLISTIC APPROACH TO ENGAGEMENT, ACTIVE PARTICIPATION WITH HEALTH AUTHORITIES AT CONFERENCES AND PUBLIC EVENTS, AND ADVANCEMENT OF KNOWLEDGE AND EDUCATION THROUGH SHARING OF INSIGHTS, LEARNINGS AND DATA. TRANSCELERATE ALSO SHARED INSIGHTS ACROSS THE R&D ECOSYSTEM: HOSTING 10 PUBLIC WEBINARS REACHING 4000+ PROFESSIONALS, PUBLISHING WHITE PAPERS TACKLING EVERYTHING FROM DECENTRALIZED TRIALS TO REAL-WORLD DATA, AND BEING FEATURED IN TOP INDUSTRY PUBLICATIONS. THE ORGANIZATION ALSO SHARED ITS VOICE AT OVER 40 LEADERSHIP-LEVEL EVENTS ACROSS 27 CITIES AND 12 COUNTRIES. THE ORGANIZATION'S WORK IN 2024 WAS AND WILL CONTINUE TO BE GEARED AROUND BUILDING A MORE EFFICIENT, PATIENT-CENTERED FUTURE FOR CLINICAL RESEARCH. | Desc |
| Total Program Service Expenses | $22,012,036 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | 0 | DescribedInSection501c3Ind |
| Schedule B Required | 0 | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Subject To Proxy Tax | Yes (1) | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | 0 | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | 0 | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | 0 | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | 0 | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | 0 | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | 0 | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | 0 | ForeignActivitiesInd |
| More Than5000 K To Org | 0 | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | 0 | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | 0 | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | 0 | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | Yes (1) | DisregardedEntityInd |
| Related Entity | 0 | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 26 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 33 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | Yes (1) | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 22 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 21 | IndependentVotingMemberCnt |
| Family Or Business Rln | 0 | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | Yes (1) | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | Yes (1) | MembersOrStockholdersInd |
| Election Of Board Members | Yes (1) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | 0 | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ANTHONY GARGES HEAD OF FINANCE AND ADMINISTRATION | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 4845391230 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 300 CONSHOHOCKEN STATE ROAD STE 420 | AddressLine1Txt |
| City | WEST CONSHOHOCKEN | CityNm |
| State Abbreviation | PA | StateAbbreviationCd |
| ZIP | 19428 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (34 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|
| JANICE CHANG | |||||||
| CEO | 40.00 | Yes (X) | Yes (X) | $1,062,291 | $0 | $42,514 | |
| KATHRYN OWEN | |||||||
| CHAIR OF BOARD OF DIRECTORS | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| BADHRI SRINIVASAN | |||||||
| VICE CHAIR OF BOARD OF DIRECTOR | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| ELIAV BARR | |||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| DIETMAR BERGER | |||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| CHRIS CORSICO | |||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| ROB GOODWIN | |||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| LYKKE HINSCH GYLVIN | |||||||
| BOARD MEMBER (EFF 6/2024) | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| NARIMON HONARPOUR | |||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| CHRISTOPH KOENEN | |||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| MARIA KOUTSOPOULOU | |||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| BARI KOWAL | |||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| FABIO LIEVANO | |||||||
| BOARD MEMBER (EFF 11/2024) | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| IRIS LOEW-FRIEDRICH | |||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| CRISTIAN MASSACESI | |||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| ROBERT METCALF | |||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| MICHELLE ROHRER | |||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| MERDAD PARSEY | |||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| MOKASH SHARMA | |||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| TOM SENDEROVITZ | |||||||
| BOARD MEMBER (EFF 4/2024) | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| TADAAKI TANIGUCHI | |||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| TAKUKO YAMADA-SAWADA | |||||||
| BOARD MEMBER | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| ULI BROEDL | |||||||
| BOARD MEMBER (THRU 6/2024) | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| MARTIN HOLST LANGE | |||||||
| BOARD MEMBER (THRU 4/2024) | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| RAGAD ATTAR | |||||||
| BOARD MEMBER (EFF-5/24/ THRU-8/24) | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| ROOPAL THAKKAR | |||||||
| BOARD MEMBER (THRU 4/2024) | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| ALLISON CUFF SHIMOOKA | |||||||
| COO | 40.00 | Yes (X) | $582,003 | $0 | $54,161 | ||
| ANDREW LEE | |||||||
| TREASURER | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| STEPHEN LIN | |||||||
| SECRETARY (THRU 11/2024) | 0.50 | Yes (X) | $0 | $0 | $0 | ||
| JENNIFER A BURGESS | |||||||
| VP, GLOBAL COMMUNICATIONS & ENGAGEMENT | 40.00 | $461,236 | $0 | $44,362 | Yes (X) | ||
| ANTHONY GARGES | |||||||
| HEAD OF FINANCE & ADMINISTRATION | 40.00 | $397,818 | $0 | $47,267 | Yes (X) | ||
| CARA L RINALDI | |||||||
| VP, PORTFOLIO MANAGEMENT | 40.00 | $417,189 | $0 | $53,497 | Yes (X) | ||
| JENEEN DONADEO | |||||||
| EXEC. PORTFOLIO DIRECTOR | 40.00 | $395,823 | $0 | $33,953 | Yes (X) | ||
| ROBERT DICICCO | |||||||
| VP, PORTFOLIO MANAGEMENT | 40.00 | $389,486 | $0 | $66,267 | Yes (X) | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $3,705,846 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $342,021 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 24 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/ForeignAddress/AddressLine1Txt | CityContractorAddress/ForeignAddress/CityNm | CountryContractorAddress/ForeignAddress/CountryCd | ServicesServicesDesc | CompensationCompensationAmt | Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd |
|---|---|---|---|---|---|---|---|---|
| PA CONSULTING GROUP INC | ||||||||
| 10 BRESSENDEN PLACE | LONDON | UK | CONSULTING SERVICES | $7,607,821 | ||||
| ACCENTURE LLP | ||||||||
| CONSULTING & IT SERVICES | $3,059,291 | 161 N CLARK STREET | CHICAGO | IL | 60601 | |||
| KILPATRICK TOWNSEND | ||||||||
| LEGAL SERVICES | $3,024,932 | 601 14TH STREET NW SUITE 900 | WASHINGTON | DC | 20005 | |||
| CDISC | ||||||||
| CONSULTING SERVICES | $1,174,012 | 401 W 15TH STREET SUITE 520 | AUSTIN | TX | 78701 | |||
| ARTEMIS FACTOR LLC | ||||||||
| CONSULTING SERVICES | $942,230 | 314 CARLYLE ROAD | WEST CHESTER | PA | 19382 | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 16 | CntrctRcvdGreaterThan100KCnt |
Program Service Revenue ProgramServiceRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | MEMBERSHIP DUES | Desc |
| Business | 541900 | BusinessCd |
| Total Revenue Column | $37,402,000 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $37,402,000 | RelatedOrExemptFuncIncomeAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $37,402,000 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $1,193,799 | TotalRevenueColumnAmt |
| Exclusion | $1,193,799 | ExclusionAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $38,595,799 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $37,402,000 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $1,193,799 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part IX | Yes (X) | InfoInScheduleOPartIXInd |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,740,969 | TotalAmt |
| Management And General | $1,740,969 | ManagementAndGeneralAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $6,642,296 | TotalAmt |
| Program Services | $4,007,775 | ProgramServicesAmt |
| Management And General | $2,634,521 | ManagementAndGeneralAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $213,770 | TotalAmt |
| Program Services | $105,657 | ProgramServicesAmt |
| Management And General | $108,113 | ManagementAndGeneralAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $735,580 | TotalAmt |
| Program Services | $442,491 | ProgramServicesAmt |
| Management And General | $293,089 | ManagementAndGeneralAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $426,538 | TotalAmt |
| Program Services | $216,100 | ProgramServicesAmt |
| Management And General | $210,438 | ManagementAndGeneralAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,092,416 | TotalAmt |
| Program Services | $1,733,598 | ProgramServicesAmt |
| Management And General | $1,358,818 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $24,450 | TotalAmt |
| Management And General | $24,450 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $14,469,089 | TotalAmt |
| Program Services | $13,251,635 | ProgramServicesAmt |
| Management And General | $1,217,454 | ManagementAndGeneralAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $56,419 | TotalAmt |
| Program Services | $13,720 | ProgramServicesAmt |
| Management And General | $42,699 | ManagementAndGeneralAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $36,218 | TotalAmt |
| Program Services | $65 | ProgramServicesAmt |
| Management And General | $36,153 | ManagementAndGeneralAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,739,885 | TotalAmt |
| Program Services | $2,133,216 | ProgramServicesAmt |
| Management And General | $606,669 | ManagementAndGeneralAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $352,881 | TotalAmt |
| Management And General | $352,881 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $494,988 | TotalAmt |
| Program Services | $107,779 | ProgramServicesAmt |
| Management And General | $387,209 | ManagementAndGeneralAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $253,413 | TotalAmt |
| Management And General | $253,413 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $253,731 | TotalAmt |
| Management And General | $253,731 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|
| RECRUITING | $175,406 | $175,406 |
| ADMINISTRATIVE FEES | $14,177 | $14,177 |
| EXCESS COMPENSATION TAX | $13,562 | $13,562 |
| BOOKS, SUBSCRIPTIONS, R | $2,200 | $2,200 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,951 | TotalAmt |
| Management And General | $1,951 | ManagementAndGeneralAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $31,739,939 | TotalAmt |
| Program Services | $22,012,036 | ProgramServicesAmt |
| Management And General | $9,727,903 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,936,830 | BOYAmt |
| EOY | $2,528,531 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $11,814,650 | BOYAmt |
| EOY | $21,990,173 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $32,162,984 | BOYAmt |
| EOY | $30,577,703 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $166,215 | BOYAmt |
| EOY | $201,619 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $26,983 | BOYAmt |
| EOY | $26,983 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $48,107,662 | BOYAmt |
| EOY | $55,325,009 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,088,338 | BOYAmt |
| EOY | $3,827,722 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $33,402,000 | BOYAmt |
| EOY | $33,003,000 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $36,490,338 | BOYAmt |
| EOY | $36,830,722 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $11,617,324 | BOYAmt |
| EOY | $18,494,287 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $11,617,324 | BOYAmt |
| EOY | $18,494,287 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $48,107,662 | BOYAmt |
| EOY | $55,325,009 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | $6,855,860 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $21,103 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | 0 | FSAuditedInd |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequiredInd |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantially All Dues Nonded | 0 | SubstantiallyAllDuesNondedInd |
| Only In House Lobbying | Yes (1) | OnlyInHouseLobbyingInd |
| Agree Carryover Prior Year | 0 | AgreeCarryoverPriorYearInd |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Written Employment Contract | Yes (X) | WrittenEmploymentContractInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (7 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JANICE CHANG | ||||||||||||||
| CEO | $785,811 | $0 | $276,480 | $0 | $0 | $0 | $13,800 | $0 | $28,714 | $0 | $1,104,805 | $0 | $0 | $0 |
| ALLISON CUFF SHIMOOKA | ||||||||||||||
| COO | $441,896 | $0 | $140,107 | $0 | $0 | $0 | $13,800 | $0 | $40,361 | $0 | $636,164 | $0 | $0 | $0 |
| JENNIFER A BURGESS | ||||||||||||||
| VP, GLOBAL COMMUNICATIONS & ENGAGEME | $341,937 | $0 | $119,299 | $0 | $0 | $0 | $13,800 | $0 | $30,562 | $0 | $505,598 | $0 | $0 | $0 |
| CARA L RINALDI | ||||||||||||||
| VP, PORTFOLIO MANAGEMENT | $309,790 | $0 | $107,399 | $0 | $0 | $0 | $0 | $0 | $53,497 | $0 | $470,686 | $0 | $0 | $0 |
| ROBERT DICICCO | ||||||||||||||
| VP, PORTFOLIO MANAGEMENT | $300,262 | $0 | $89,224 | $0 | $0 | $0 | $7,594 | $0 | $58,673 | $0 | $455,753 | $0 | $0 | $0 |
| ANTHONY GARGES | ||||||||||||||
| HEAD OF FINANCE & ADMINISTRATION | $269,134 | $0 | $128,684 | $0 | $0 | $0 | $13,800 | $0 | $33,467 | $0 | $445,085 | $0 | $0 | $0 |
| JENEEN DONADEO | ||||||||||||||
| EXEC. PORTFOLIO DIRECTOR | $304,859 | $0 | $90,964 | $0 | $0 | $0 | $13,800 | $0 | $20,153 | $0 | $429,776 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 3 | FormAndLineReferenceDesc |
| Explanation | THE BOARD CHAIR, WITH INPUT FROM OTHER DIRECTORS OR A SUBCOMMITTEE OF THE BOARD, ANNUALLY REVIEWS AND APPROVES THE CEO'S COMPENSATION PACKAGE. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (9 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART I, LINE 6, TOTAL NUMBER OF VOLUNTEERS: | THE TOTAL NUMBER OF VOLUNTEERS OF 27, ENCOMPASSES ALL ACTIVE BOARD MEMBER THROUGHOUT THE CALENDAR YEAR. |
| FORM 990, PART VI, SECTION A, LINE 4 | DURING 2024, THE BOARD OF DIRECTORS OF THE CORPORATION APPROVED AMENDING THE BYLAWS OF THE CORPORATION TO: (A) INCREASE FROM FIVE (5) TO SEVEN (7) THE NUMBER OF BOARD SEATS TO BE FILLED BY DIRECTORS WHO ARE REPRESENTATIVES OF THE TIER I MEMBERS WHO ARE NOT CHARTER MEMBERS, AND ACCORDINGLY TO INCREASE THE TOTAL NUMBER OF DIRECTORS FROM 22 TO 24 TO REFLECT SUCH INCREASE; AND (B) ADJUST THE MEMBERSHIP TIER ELIGIBILITY THRESHOLDS AS DESCRIBED IN LINE 6 BELOW. |
| FORM 990, PART VI, SECTION A, LINE 6 | THE MEMBERS OF THE CORPORATION CONSIST OF SUCH FIRMS AND CORPORATIONS THAT ARE APPROVED FOR MEMBERSHIP FROM TIME TO TIME BY THE BOARD OF DIRECTORS OR ITS DESIGNEES IN ACCORDANCE WITH THE POLICIES AND PROCEDURES OF THE CORPORATION. THE CORPORATION HAS THE FOLLOWING CATEGORIES OF MEMBERS: A. TIER I MEMBERS - TO BE ELIGIBLE FOR TIER I MEMBERSHIP, A FIRM OR CORPORATION MUST BE A PHARMACEUTICAL OR BIOTECHNOLOGY COMPANY WITH AN ANNUAL BUDGET FOR RESEARCH AND DEVELOPMENT IN EXCESS OF AN AMOUNT EQUAL TO $3.3 BILLION AS OF JANUARY 1, 2024, WHICH AMOUNT SHALL THEREAFTER BE ADJUSTED FOR INFLATION IN ACCORDANCE WITH THE U.S. CPI INDEX (THE "TIER I THRESHOLD"). THE ADJUSTED TIER I THRESHOLD SHALL BE ANNOUNCED TO THE MEMBERS PERIODICALLY BY THE FINANCE COMMITTEE OR THE BOARD OF DIRECTORS. ELIGIBILITY FOR TIER I MEMBERSHIP IS ESTABLISHED BASED UPON THE AVERAGE OF A COMPANY'S PUBLICALLY AVAILABLE RESEARCH AND DEVELOPMENT EXPENDITURES OVER THE PRECEDING THREE (3) YEAR PERIOD. THE INITIAL TIER I MEMBERS ARE FURTHER DEFINED AS THE "CHARTER MEMBERS." B. TIER II MEMBERS - TO BE ELIGIBLE FOR TIER II MEMBERSHIP, A FIRM OR CORPORATION MUST BE A PHARMACEUTICAL OR BIOTECHNOLOGY COMPANY WITH AN ANNUAL BUDGET FOR RESEARCH AND DEVELOPMENT THAT IS LESS THAN THE TIER I THRESHOLD BUT MORE THAN AN AMOUNT EQUAL TO $134 MILLION AS OF JANUARY 1, 2024, WHICH AMOUNT SHALL THEREAFTER BE ADJUSTED FOR INFLATION IN ACCORDANCE WITH THE U.S. CPI INDEX (THE "TIER II THRESHOLD"). THE ADJUSTED TIER II THRESHOLD SHALL BE ANNOUNCED TO THE MEMBERS PERIODICALLY BY THE FINANCE COMMITTEE OR THE BOARD OF DIRECTORS.. ELIGIBILITY FOR TIER II MEMBERSHIP WILL BE ESTABLISHED BASED UPON THE AVERAGE OF A COMPANY'S PUBLICALLY AVAILABLE RESEARCH AND DEVELOPMENT EXPENDITURES OVER THE PRECEDING THREE (3) YEAR PERIOD. C. ASSOCIATE MEMBERS - TO BE ELIGIBLE FOR ASSOCIATE MEMBERSHIP, A FIRM OR CORPORATION MUST BE A PHARMACEUTICAL OR BIOTECHNOLOGY COMPANY WITH AN ANNUAL BUDGET FOR RESEARCH AND DEVELOPMENT THAT IS LESS THAN THE TIER II THRESHOLD. |
| FORM 990, PART VI, SECTION A, LINE 7A | THE BOARD OF DIRECTORS SHALL BE COMPRISED OF UP TO TWENTY-FOUR (24) DIRECTORS; PROVIDED THAT: (I) TEN (10) SEATS ARE FILLED BY DIRECTORS WHO ARE REPRESENTATIVES OF THE CHARTER MEMBERS; (II) UP TO SEVEN (7) ADDITIONAL SEATS SHALL BE FILLED BY DIRECTORS WHO ARE REPRESENTATIVES OF THE TIER I MEMBERS WHO ARE NOT CHARTER MEMBERS; (III) UP TO SIX (6) SEATS SHALL BE FILLED BY DIRECTORS WHO ARE REPRESENTATIVES OF THE TIER II MEMBERS; AND (IV) ONE (1) SEAT SHALL BE FILLED BY THE CHIEF EXECUTIVE OFFICER OF THE CORPORATION. THE CORPORATION'S BYLAWS STATE THAT DIRECTORS SHALL BE ELECTED OR APPOINTED, AS APPLICABLE, ANNUALLY AT THE ANNUAL MEETING OF MEMBERS AND SHALL SERVE UNTIL THE FOLLOWING ANNUAL MEETING OF MEMBERS AND UNTIL THEIR SUCCESSORS ARE ELECTED OR APPOINTED, AS APPLICABLE, AND QUALIFIED. EACH CHARTER MEMBER SHALL HAVE THE RIGHT TO APPOINT A REPRESENTATIVE OF THE CHARTER MEMBER TO SERVE AS A CHARTER MEMBER DIRECTOR. TIER I AT-LARGE DIRECTORS SHALL BE ELECTED BY A PLURALITY VOTE OF THE TIER I MEMBERS, WHICH INCLUDE THE CHARTER MEMBERS. TIER II DIRECTORS SHALL BE ELECTED BY A PLURALITY VOTE OF THE TIER II MEMBERS. THE CEO DIRECTOR SHALL SERVE EX-OFFICIO, FOR SO LONG AS HE OR SHE SHALL HOLD THE OFFICE OF CHIEF EXECUTIVE OFFICER. EACH TIER I MEMBER SHALL BE ENTITLED TO THREE (3) VOTES AT EVERY MEETING OF MEMBERS ON MATTERS WHICH TIER I MEMBERS ARE ENTITLED TO VOTE. EACH TIER II MEMBER SHALL BE ENTITLED TO ONE (1) VOTE AT EVERY MEETING OF MEMBERS ON MATTERS WHICH TIER II MEMBERS ARE ENTITLED TO VOTE. ASSOCIATE MEMBERS SHALL BE ENTITLED TO NOTICE OF AND TO ATTEND MEETINGS OF THE MEMBERS BUT SHALL NOT BE ENTITLED TO VOTE AT SUCH MEETINGS. NOTWITHSTANDING THE ABOVE, IN ORDER TO BE ELIGIBLE TO VOTE, A MEMBER MUST BE IN GOOD STANDING AND ITS DUES AND ASSESSMENTS PAID IN FULL. |
| FORM 990, PART VI, SECTION B, LINE 11B | THE FINANCE COMMITTEE AND MANAGEMENT REVIEW AND APPROVE THE FORM 990. THE FORM IS THEN DISTRIBUTED TO ALL MEMBERS OF THE BOARD FOR THEIR REVIEW BEFORE FILING WITH THE INTERNAL REVENUE SERVICE. |
| FORM 990, PART VI, SECTION B, LINE 12C | EACH DIRECTOR AND OFFICER OF THE CORPORATION IS REQUIRED TO ANNUALLY ACKNOWLEDGE THE CONFLICT OF INTEREST POLICY, AFFIRMING THAT SUCH PERSON HAS RECEIVED, READ AND UNDERSTANDS, AND AGREED TO COMPLY WITH THE CONFLICT OF INTEREST POLICY. |
| FORM 990, PART VI, SECTION B, LINE 15 | THE ORGANIZATION'S EXECUTIVE COMPENSATION COMMITTEE, CONSISTING OF INDEPENDENT DIRECTORS, ANNUALLY REVIEWS AND APPROVES THE CEO'S COMPENSATION PACKAGE. THE CEO APPROVES THE COMPENSATION FOR THE CHIEF OPERATING OFFICER, AND ALL OTHER KEY EMPLOYEES. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE ORGANIZATION'S GOVERNING DOCUMENTS, FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY AND OTHER CORPORATE POLICIES ARE AVAILABLE UPON REQUEST. |
| FORM 990, PART IX, LINE 11G | PROJECT MANAGEMENT FEES: PROGRAM SERVICE EXPENSES 11,209,160. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 11,209,160. EXTERNAL CONTRACTOR SUPPORT: PROGRAM SERVICE EXPENSES 1,959,060. MANAGEMENT AND GENERAL EXPENSES 210,229. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 2,169,289. COMMUNICATIONS FEES: PROGRAM SERVICE EXPENSES 83,415. MANAGEMENT AND GENERAL EXPENSES 1,007,225. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,090,640. |
Schedule R IRS990ScheduleR
Id Disregarded Entities IdDisregardedEntitiesGrp
Disregarded Entity Name DisregardedEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | BIOCELERATE LLC | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 300 CONSHOHOCKEN STATE ROAD STE 420 | AddressLine1Txt |
| City | WEST CONSHOHOCKEN | CityNm |
| State Abbreviation | PA | StateAbbreviationCd |
| ZIP | 19428 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 475492971 | EIN |
| Primary Activities | TO IMPROVE EFFICIENCIES IN PRECLINICAL RESEARCH. | PrimaryActivitiesTxt |
| Legal Domicile State | DE | LegalDomicileStateCd |
| Total Income | $1,351,218 | TotalIncomeAmt |
| End Of Year Assets | $1,565,545 | EndOfYearAssetsAmt |
Direct Controlling Entity Name DirectControllingEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | TRANSCELERATE BIOPHARMA INC | BusinessNameLine1Txt |